The latest clinical trial data for subcutaneous (SC) infliximab (CT-P13 SC), presented at the United European Gastroenterology (UEG) Week 2023 in Copenhagen, further support the potential of CT-P13 SC ...
A clinical-stage pharmaceutical company based in Essex, Thetis Pharmaceuticals LLC, has secured $9 million in funding in the form of a loan from The Leona M. and Harry B. Helmsley Charitable Trust.
TUESDAY, Dec. 30, 2025 (HealthDay News) — Early changes in a person's gut bacteria might herald the onset of inflammatory ...
A new drug for treating a type of inflammatory bowel disease (IBD) has been given the go-ahead by the Food and Drug Administration. On Friday, the FDA approved Pfizer’s etrasimod, branded as Velsipity ...
A soft, wireless implant treats inflammatory bowel disease by tapping into the body’s neural network
Scientists have created a groundbreaking, fully implantable neurostimulator made entirely of soft hydrogel to treat inflammatory bowel disease (IBD). Unlike traditional rigid and wired implants, this ...
Picture this common clinical scenario: A patient has chronic diarrhea, abdominal pain, and weight loss. Blood and stool tests point to inflammatory bowel disease (IBD). But which one -- Crohn's ...
It can be overwhelming to receive a diagnosis of inflammatory bowel disease (IBD), a condition which refers to the chronic diseases that can cause inflammation in your gastrointestinal (GI) tract.
What Is Proctitis and How Does It Compare to UC? Proctitis is inflammation of the rectum, the last part of the large intestine that connects the colon to the anus. Ulcerative colitis (UC) is a type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback